Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Alibaba Health Information Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Alibaba Health Information Technology şirketinin toplam hissedar öz sermayesi CN¥14.5B ve toplam borcu CN¥0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥19.7B ve CN¥5.2B dir. Alibaba Health Information Technology 'in FAVÖK'ü CN¥637.4M faiz karşılama oranı -1.3 dur. Şirketin CN¥9.6B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

CN¥0

Borç

Faiz karşılama oranı	-1.3x
Nakit	CN¥9.55b
Eşitlik	CN¥14.52b
Toplam yükümlülükler	CN¥5.19b
Toplam varlıklar	CN¥19.71b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 241 'nin kısa vadeli varlıkları ( CN¥13.5B ) kısa vadeli yükümlülüklerini ( CN¥5.0B ) aşıyor.

Uzun Vadeli Yükümlülükler: 241 şirketinin kısa vadeli varlıkları ( CN¥13.5B ) uzun vadeli yükümlülüklerini ( CN¥162.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 241 borçsuzdur.

Borcun Azaltılması: 241 şirketinin 5 yıl önce borç/öz sermaye oranı 62.1% iken borcu yok.

Borç Kapsamı: 241 un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 241 şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Alibaba Health Information Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Investor sentiment deteriorates as stock falls 24%

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023)

Alibaba Health Information Technology Limited, Annual General Meeting, Aug 30, 2024

Executive Chairman of the Board recently sold HK$559k worth of stock

Investor sentiment improves as stock rises 15%

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023)

Alibaba Health Information Technology Limited to Report Fiscal Year 2024 Results on May 27, 2024

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 18%

New minor risk - Shareholder dilution

First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023)

Alibaba Health Information Technology Limited Announces Executive Changes

Alibaba Health Information Technology Limited to Report First Half, 2024 Results on Nov 28, 2023

Alibaba Health Information Technology Limited Appoints Xu Haipeng as Non-Executive Director

Less than half of directors are independent

Alibaba Health Information Technology Limited Announces Executive Changes and Committee Changes

Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022)

Alibaba Health Information Technology Limited, Annual General Meeting, Aug 11, 2023

Chairman of the Board & CEO recently sold HK$587k worth of stock

Less than half of directors are independent

Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022)

Alibaba Health Information Technology Limited Announces Board Changes

Alibaba Health Information Technology Limited to Report Fiscal Year 2023 Final Results on May 23, 2023

Alibaba Health Information Technology Limited Provides Earnings Guidance for the Year Ended March 31, 2023

First half 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.017 loss in 1H 2022)

Alibaba Health Information Technology Limited to Report Q2, 2023 Results on Nov 28, 2022

Less than half of directors are independent

Alibaba Health Information Technology Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2022

Now 21% undervalued

Now 20% undervalued

Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021)

Alibaba Health Information Technology Limited, Annual General Meeting, Aug 05, 2022

Alibaba Health Information Technology Limited Announces Executive Changes

Now 21% undervalued

Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021)

Alibaba Health Information Technology Limited to Report Fiscal Year 2022 Final Results on May 25, 2022

Less than half of directors are independent

Less than half of directors are independent

COO & Executive Director recently bought HK$4.5m worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Chairman of the Board & CEO recently bought HK$3.4m worth of stock

Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020)

CFO & Executive Director recently bought HK$284k worth of stock

CFO & Executive Director recently bought HK$284k worth of stock

Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020)

CFO & Executive Director recently sold HK$906k worth of stock

New 90-day high: HK$28.90

New 90-day high: HK$27.45

New 90-day high: HK$23.20

New 90-day high: HK$23.00

Alibaba Health Information Technology Limited to Report First Half, 2021 Results on Nov 25, 2020

Non-Executive Director recently sold HK$6.9m worth of stock

New 90-day low - HK$17.40

Alibaba Health Information Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 10 billion.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin